Embed Size (px)
Citation preview
ESSCPEuropean Society of Clinical Pharmacy
ESCP International Workshop
30 May–1 June 2012 Leuven, BELGIUMPreliminary Programme
PATIEnTs, InfEcTIons AnD THE clInIcAl PHArMAcIsT
ESCP IntErnatIonal offICEVoorstraat 13NL-9285 NM BuitenpostThe NetherlandsTel: +31 645 915 831 Fax: + 31 511543660Email: [email protected] www.escpweb.org
organISIng SECrEtarIatMomentum Grensstraat 8B-3010 LeuvenContact person: Mieke Akkers E-mail: [email protected] +32.16.404555 Fax +32.16.403551
WorKSHoP WEbSItEinformation, registration, accommodation. Please find on the website all updates of the program. www.escpweb.org
WorKSHoP CoMMIttEESChair of the WorkshopGert Laekeman - Belgium
local organizing CommitteeSiska Desplenter, BelgiumErik Gerbrands, The NetherlandsGert Laekeman, BelgiumHugo Robays, BelgiumJenny Vijverman, BelgiumLudo Willems, Belgium
Scientific CommitteeFranky Buyle, BelgiumSiska Desplenter, BelgiumVeerle Foulon, BelgiumGert Laekeman, BelgiumPiera Polidori, ItalyDaniela Scala, ItalySteven Simoens, BelgiumIsabel Spriet, BelgiumVera von Gunten, Switzerland
ESCP general CommitteeCecilia Bernsten, Sweden ESCP PresidentOlivier Bourdon, FranceSiska Desplenter, Belgium Vice PresidentSiska Desplenter, Belgium TreasurerAnne Gerd Granås, NorwayMarkus Lampert, Switzerland Anne Leendertse, The Netherlands SecretaryPiera Polidori, ItalyMartin Schulz, Germany
ESSCPEuropean Society of Clinical Pharmacy
01 Content
Invitation from the Presidents ..................................................... 2
Generalities ................................................................................ 3Call for Abstracts ......................................................................... 4General Informations .................................................................. 7Registration and Accommodation ................................................ 8Sponsorship and Exhibition Opportunities ................................... 12
Scientific Programme .............................................................. 13Wednesday, May 30, 2012 ..... .................................................... 14Thursday, May 31, 2012 ............................................................... 15Friday, June 1, 2012 ..................................................................... 19
Programme at a Glance ........................................................... 10–11
02 WelCome to the eSCP InternatIonal WorkShoP In leuven !
Dear Colleagues,
The emerging enterhaemorragic E. coli reminds us of our vulnerability for infections. Two years ago we had the fear for the H1N1 flu epidemy. Opportunistic infections like TBC can complicate the use of TNFalpha antagonists. Systemic mycoses remain life threatening as infected patients are mostly in a bad condition. MRSA is always looking around the edge … Enough examples for more than contemplation.
Whether in the hospital or in the community: infections come as such or they complicate existing conditions. We try to master them on a rational way, in accordance with the mission of ESCP: ... developing and promoting the rational and appropriate use of medicines, medical products and devices by the individual and by society … However, when we have to take into account too many variables, some of them with an emotional component, we may tend to forget about rational guide-lines and rules. On the one hand over-reacting and moving away from rationality can happen from the professional side. On the other hand second thoughts about costs and side effects may disturb the opinion of patients. Anti-vaccination and anti-antibiotic feelings can hamper prevention and treat-ment. Especially in case of long-lasting treatments compliance and adherence become important for a positive outcome.On top of that, resistance of micro-organisms against the medicines available keeps us vigilant. To what extent guidelines and development of new antimicrobial agents may solve the problem? What to do if the preferential treatment seriously interacts with other important medicines?
‘Patients, infections and the clinical pharmacist’ can be considered as pattern to be used for a nice lacework as you have probably already seen in Flanders. We want to weave this piece of lace in Leu-ven from 30 May to 1 June 2012. It takes only 15 minutes from the international airport of Brussels to the city of Leuven. We will welcome you on the campus ‘Gasthuisberg’ of the university hospital. Plenary lectures, interactive working sessions and poster presentations are planned during daytime. In the evening there is the enjoying atmosphere of an historical city, since 1425 a home for thousands of students. At least from the infectious side, a beer on a terrace remains safe and pleasant restaurants guarantee an affordable price-quality balance.
See you in Leuven!
Gert LaekemanChair of the Workshop
Cecilia Bernsten ESCP President
Generalities
Call for abstracts 4
General Informations 7
Registration and Accommodation 8
Sponsorship and Exhibition Opportunities 12
05
The
Quay
s Ba
r, Du
blin
Gert LaekemanChair of the Workshop
Cecilia Bernsten ESCP President
Generalities
04
Gen
eral
ities
Call for abStraCtS
abstract submission deadline: 5 march 2012Abstracts must be submitted on-line via the workshop website: www.escpweb.orgAbstracts sent by mail, fax or e-mail will NOT be accepted.Only abstracts related to the topic of infections will be considered for review.Please follow the instructions on the screen. For questions regarding the on-line submission process, e-mail: [email protected] selection of abstracts for oral and poster presentations will be made by the Scientific Committee in April 2012. The presenting authors will receive an e-mail with the result of the review and the Scientific Committee’s decision on the abstract by mid April 2012.
abstract policy and regulationsWith the submission of an abstract to the ESCP 2012 workshop, the first (presenting) author: accepts responsibility for the accuracy of the submitted abstract (please proofread the
abstract carefully prior to submission!); accepts to be the contact person for all correspondence about the abstract and inform co-
authors about its status; confirms that all co-authors are aware of and agree to the content of the abstract and
support the data presented; indicates clearly in the submission, and later also mentions on the poster, if the material
was presented or published elsewhere prior to the meeting; identifies any conflict of interest (e.g. through involvement with a pharmaceutical
company) in the abstract, the poster and the presentation; releases the copyright to ESCP and gives permission for the abstract, when selected for
presention, to be published in the ESCP 2012 abstract book as well as on the official ESCP website and in the International Journal of Clinical Pharmacy – IJCP.
Guidelines for writing a structured abstractA badly written abstract will distract from the quality of the work and this may result in the work not being accepted for presentation. The abstract must convey the important information, which will eventually be contained in
the full paper or presentation. The abstract must be intelligible and understandable when read (i.e. precise, clear and
rigour). The abstract must be written in proper and understandable English. Before printing or typing the abstract body make sure that you do not exceed the number
of 350 words permitted. A structured abstract should not include illustrations, figures or tables.
Generalities
05Call for abStraCtS
abstract format The title of the abstract should be brief, specific and informative (max. 160 characters). No more than 10 co-authors can be listed. The body of the abstract can be max. 350 words. Drugs should be referred to by their approved (not proprietary) name. Undefined abbreviations should not be used. Scientific measurements should be in SI units (except blood pressure in mm Hg). Statistical methods should be defined and referenced if not in common use. The number of patients or subjects studied should be clearly stated. The abstract should be structured in such a way as to include the following sections:
1. background and objective: the question or problem addressed by the study must be clear
2. Design: the basic design of the study, statistical method 3. Setting: the location of the study 4. main outcome measures: the parameters used to judge the results in order to fulfil
the study; for a new treatment the variables on which the efficacy/effectiveness is tested. 5. results: the description of the results should be brief and precise. Only representative
data need to be provided. Avoid phrases like "Results will be shown". 6. Conclusions: the brief conclusion(s) should follow logically from the objective, main
outcome measurers and results of the study and abstract. The following are some of the common reasons why abstracts are referred for correction or rejected by a scientific committee: inappropriate title; lacking in rigorous study design and/or methodology in a research abstract; the objectives and conclusions are not clear; conclusions do not follow from the objectives and results; questionable statistical analysis; inadequate information which does not permit the abstract to be understood; inadequate data which does not permit the abstract to be evaluated; not relevant to clinical pharmacy; lacking in novelty and originality or having predictable results; the submission does not conform to requirements for the layout and presentation of
abstracts; bad use of the English language, leading to misunderstandings.
Please visit http://www.escpweb.org/cms/node/145 for the ESCP guidelines for scientific presentations.
Gen
eral
ities
06
abstract submission procedure Abstracts must be submitted on-line, through www.escpweb.orgThe first (presenting) author's name and contact details are crucial for future correspondence.Final submission procedure: When finished with the on-line submission, it is imperative to click the "Final submission"
button for final submission of the abstract; a screen will then appear informing that the abstract has been registered successfully. Within 48 hours of submission, the presenting author will receive an e-mail to verify that the organiser has received the abstract. This confirmation of abstract receipt is NOT a notice of acceptance.
In case the confirmation from the organiser is not received, the presenting author should contact [email protected] within one week of submission of the abstract.
Once the abstract is submitted, changes, corrections or rewording are not possible. Careful typing and proof-reading are essential as the abstract will not be edited or corrected by the organiser and will appear, if accepted, as submitted.
Submitting an abstract for presentation at the ESCP 2012 workshop does not constitute registration for the workshop. Abstract presenters must register to attend the ESCP 2012 workshop by following the instructions for registration on this website. abstract presenters can benefit from the early deadline registration until 20 april 2012. abstract presenters must register by 20 april 2012.
abstract selection process Abstracts submitted for presentation at the ESCP 2012 workshop will be reviewed by an international panel of experts in the field of the subject and will be judged solely on the data submitted.The following presentation formats are applicable at the ESCP 2012 workshop:Oral communication: Oral communications consist of 15-minute presentations by the authors on the content of their abstracts, including 5-minute discussions with questions and answers. The authors of oral communications do not need to present a poster of their abstract.Poster presentation: Abstracts that have been selected for presentation in poster format will be displayed on poster boards for the duration of the workshop. The authors will receive the guidelines for oral and poster presentations upon acceptance of their abstract.
Withdrawal of abstractsAbstracts submitted for presentation at the ESCP 2012 workshop can be withdrawn until 20 April 2012. If the presenting author of a selected abstract cannot attend, she or he should assign one of the co-authors as presenting author and inform the organising secretariat of the replacement as soon as possible. If an abstract presenter is not registered by 20 April 2012, her or his abstract will not be published in the abstract book.
Call for abStraCtS
Generalities
07
Generalities
Generalities
Workshop venueUniversity Hospital GasthuisbergOnderwijs en Navorsing – ON2Herestraat 49 B-3000 LeuvenBelgium
For detailed information on location and access, please visit the workshop website: www.escpweb.org
Workshop languageThe official language of the workshop will be English. No simultaneous translation will beavailable.
CurrencyThe official currency in Belgium is EURO (EUR). Most foreign currencies can be converted in banks, hotels or exchange offices. International credit cards are accepted in most hotels, res-taurants and shops.
InsuranceThe organiser does not accept responsibility for individual medical, travel or personal in-surance. Participants are strongly advised to take out their own arrangements in respect of health and travel insurance.
Passport and visa informationA valid passport and/or identity card is required for all participants. Visa may be required for some countries. For specific information, please contact the nearest Belgian embassy at least six weeks before your departure to Belgium.
Social programmeThe following social events are organised on the occasion of the workshop:Welcome reception: Wednesday 30 May 2012 at 19.00 in the City Hall. Participation is complimentary.Conference dinner: Thursday 31 May 2012 at 19.30 in the Faculty Club, Grand Beguinage. Registration fee: 75 EUR per person.
General InformatIonS
Gen
eral
ities
08
Workshop registrationEarly registration deadline: 5 March 2012Pre-registration should be received before 23 May 2012. After this date, registrations are accepted on-site in Leuven only. If at all possible, please register on-line: www.escpweb.orgor download the registration form from the website: www.escpweb.org
PaymentFull payment in Euro (EUR) should accompany your registration. It is possible to pay by: Eurocard/Mastercard and Visa. Please indicate the owner’s name as shown on the card; Direct bank transfer into the ESCP 2012 account n°. IBAN BE48 4220 0282 8927 with
KBC Bank, BIC/SWIFT Code KREDBEBB, Heverlee Park.For ease of processing, please indicate clearly the name of the participant and mention ‘Registration for ESCP 2012’ on the transfer document.Registrations on-site can be paid by credit card (Eurocard/Mastercard or Visa) or cash in EUR.
Confirmation of registrationA confirmation of registration will be sent to each participant. The confirmation letter should be presented at the registration desk in order to receive the congress bag and badge.
reGIStratIon anD hotel aCCommoDatIon
Category Early Rate* (deadline 5 march
12)
Late Rate (deadline 23
May )
Desk Rate(after 23 May 12
and on-site)
ESCP Member 1 430,00 € 530,00 € 630,00 €
Non-member 580,00 € 680,00 € 780,00 €
One day member 1+2 230,00 € 330,00 € 380,00 €
One day non-member 330,00 € 430,00 € 480,00 €
1 Membership rate applies to ESCP members. 2 ‘One-day registration’ is for persons who wish to attend only 1 day of the workshop. It is not
allowed to combine several one day rates. As soon as you attend more than 1 day, the full registration fee is applicable.
* Presenters of accepted abstracts will have the possibility to register at the early registration fee until 20 April 2012 .
09
Generalities
reGIStratIon anD hotel aCCommoDatIon
Continuing education creditsPharmacists from Belgium, Croatia, Czech Republic, Finland, France, Germany, Portugal,Switzerland, the Netherlands and the United Kingdom can obtain continuing education credits for attending ESCP courses and symposia. For more information, please contact the ESCP International Office or visit the ESCP stand during the workshop.
CancellationCancellations of confirmed registrations are subject to a charge of 75 EUR per participant provided the cancellation is received before 23 April 2012. After this date no refunds will be made.
Contact of the organising secretariatMomentum, Grensstraat 8, B-3010 LeuvenContact person: Mieke Akkers E-mail: [email protected] +32.16.404555; Fax +32.16.403551
hotel booking: General informationA hotel room can be booked during the online registration process. For hotel reservations please e-mail: [email protected] deadline for hotel reservation is 16 april 2012. After this date accommodation cannot be guaranteed by the organiser. Reservations are made on a first-come, first-served basis and delegates are advised to book early.
hotel cancellation / modification terms and conditionsIn order to verify Terms and Conditions please contact the conference secretariate-mail: [email protected]; phone +32.16.404555; fax +32.16.403551
Programme at a glance
time Wednesday, 30 may 2012 thursday, 31 may 2012 Friday, 1 June 2012
Infections across care Pharmacotherapy: selected topics in infections Infections from a societal perspective
08:00–08:30
Plen
ary
Se
ssio
n 2a
l 2.1: Clinical breakpoints: EUCAST versus CLSI
Plen
ary
Se
ssio
n 3 a
l 3.1: Vaccination: victim of its own success? (from 8:00 to 8:45)
08:30–09:00 l 2.2: Mycobacterial infections: problems of resistancel 3.2: (Cost-)effectiveness of vaccination (from 8:45 to 9:30)
09:00–09:30 l 2.3: Resistance in Gram-negative infections: dosing strategies
09:30–10:00 COFFEE BREAK – Poster viewing – Exhibition COFFEE BREAK – Poster viewing – Exhibition
10:00–10:30
Wor
ksho
p 1
– 5
re
peat
ed
WS 1:Interactions with anti-microbial agents
WS 2: Urinaryinfections
WS 3:Adherence in long-lasting therapies
WS 4:Preven-tion of infectious diseases
WS 5:State-of-the-art workshop on CAPinfections
Wor
ksho
p 6
– 10
re
peat
ed
WS 6:Bacterial infections in pediatric oncology: theoretical and practi-cal issues
WS 7:Anti- microbial Steward-ship
WS 8:Resistant Gram-negative infections
WS 9:Sup-porting guide-lines in infectious diseases
WS 10:Infections related to travelling
10:30–11:00
11:00–11:30
11:30–12:00
12:00–12:30 LUNCH – Poster viewing – ExhibitionPfizer guest lecture
LUNCH – Poster viewing – ExhibitionVSm guest lecture
12:30–13:00 registration open
13:00–13:30 Poster viewing – Exhibition oral communications 1 oral communications 2
13:30–14:00 opening ceremony
14:00–14:45
Plen
ary
se
ssio
n 1a
l 1.1: Prosthetic Joint Infection
Wor
ksho
ps 6
– 1
0
WS
6: B
acte
rial i
n-fe
ctio
ns in
ped
iatri
c on
colo
gy: t
heor
etic
al
and
prac
tical
issu
es
WS
7: A
ntim
icro
bial
St
ewar
dshi
p
WS
8: R
esis
tant
Gr
am-n
egat
ive
in
fect
ions
WS
9: S
uppo
rting
gu
idel
ines
in
infe
ctio
us d
isea
ses
WS
10: I
nfec
tions
re
late
d to
trav
ellin
g
Plen
ary
Se
ssio
n 3 B
l 3.3: Antimicrobial pharmacist: training & experience
14:45–15:30 l 1.2: Cystic fibrosis: from hospital to community l 3.4: Perspectives in antimicrobial agents
15:30–16:00 COFFEE BREAK – Poster viewing – Exhibition Summary of workshop & closing ceremony
16:00–16:30
Wor
ksho
ps 1
– 5
WS
1: In
tera
ctio
ns w
ith
antim
icro
bial
age
nts
WS
2: U
rinar
y in
fect
ions
WS
3: A
dher
ence
in lo
ng-
last
ing
ther
apie
s
WS
4: P
reve
ntio
n of
in
fect
ious
dis
ease
s
WS
5: S
tate
-of-t
he-a
rt w
orks
hop
on C
AP in
fect
ions COFFEE BREAK – Poster viewing – Exhibition
16:30–17:00
Plen
ary
Se
ssio
n 2B
l 2.4: Therapeutic drug monitoring of antimicrobial agents
17:00–17:30 l 2.5: Invasive fungal infections: what should the clinical pharma-cist know about it?
17:30–18:00 l 2.6: Opportunistic infections
19:00–19:30 Welcome reception – leuven city Hall
19:30–20:00 Workshop Dinner - Faculty club (Beguinage)
10 11
12
Gen
eral
ities
SPonSorShIP anD eXhIbItIon oPPortunItIeS
Sponsorship and exhibitionthe sponsorship opportunities offer something for every budget and marketing strategy to raise your company’s profile with a combination of advertising, sponsorship and other promotional items. An exhibition will be organised in the framework of the workshop. The exhibition will be located in the workshop venue, right outside the main auditorium in the area where the coffee breaks, lunches and poster sessions will be organised. In addition, a wide range of additional promotional items ranging from inserts in delegates bags, to pens, adverts and more is also being offered.
Contact for exhibitors and sponsorsTo reserve your space and participation today or to know more about promotional opportunities, please download the Sponsorship brochure from www.escpweb.org or contact Professor G. laekeman by e-mail: [email protected]
We are grateful counting already by now the following companies among our exhibitors/sponsors for the eSCP international workshop 2012:
eSCP 2012 Workshop partner: Pfizer
Sponsors & exhibitors: Janssen-Cilag nv Roche VSM Belgium FWO-Vlaanderen
Wednesday
Scientific ProgrammeWednesday, 30 May 2012
SCIentIfIC ProGramme of the Day
Grote-Markt, Leuven
14
Wed
nesd
ay
InfeCtIonS aCroSS Care
This is the preliminary programme on date of printing and is subject to change. For regular updates, please consult the website: www.escpweb.org
SCIentIfIC ProGramme of the Day
time afternoon Programme
12:30 – 13:30 registration – Poster viewing – Exhibition
13:30 – 14:00 opening ceremonyInfectious diseases and antiinfective treatment in the new era. Willy Peetermans, Belgium
14:00 – 15:30 Plenary Session 1a:
14:00 – 14:45 l 1.1: Prosthetic Joint Infection: from pathophysiology to management.Willy Peetermans, Belgium
14:45 – 15:30 l 1.2: Treatment of cystic fibrosis: from hospital to community. Kris De Boeck, Belgium
15:30 – 16:00 Coffee Break– Poster viewing – Exhibition
16:00 – 18:00 Workshops 1 – 5 (The summaries of the workshops will be available on the symposium website by Mid March 2012.)
WS 1: Interactions with antimicrobial agents.Pieter De Cock – Isabel Spriet, BelgiumWS 2: Urinary infections: treatment, counselling and referral.Thierry Christiaens, BelgiumWS 3: Adherence in long-lasting therapies (HIV-TBC).Inge Derdelinckx, BelgiumWS 4: Prevention of infectious diseases: role of the pharmacist.Annette Schuermans, BelgiumWS 5: State-of-the-art workshop on CAP infections.Pascal Van Bleyenbergh, Belgium
19:00 Welcome Reception at Leuven City Hall
thursday
Scientific ProgrammeThursday, 31 May 2012
Stationsgebouw, Leuven
16
thur
sday
PharmaCotheraPy: SeleCteD toPICS In InfeCtIonS
This is the preliminary programme on date of printing and is subject to change. For regular updates, please consult the website: www.escpweb.org
SCIentIfIC ProGramme of the Day
time morning Programme
08:00 – 09:30 Plenary Session 2a:
08:00 – 08:30 l 2.1: Clinical breakpoints: EUCAST versus CLSI.Greet Leven, Belgium
08:30 – 09:00 l 2.2: Mycobacterial infections: problems of resistance.Steven Callens, Belgium
09:00 – 09:30 l 2.3: Resistance in Gram-negative infections: dosing strategies.Frédérique Jacobs, Belgium
09:30 – 10:00 Coffee Break– Poster viewing – Exhibition
10:00 – 12:00 Workshops 1 – 5 repeated (The summaries of the workshops will be available on the symposium website by Mid March 2012.)
WS 1: Interactions with antimicrobial agents. Pieter De Cock, Isabel Spriet, BelgiumWS 2: Urinary infections: treatment, counselling and referral.Thierry Christiaens, BelgiumWS 3: Adherence in long-lasting therapies (HIV-TBC).Inge Derdelinckx, BelgiumWS 4: Prevention of infectious diseases: role of the pharmacist.Annette Schuermans, BelgiumWS 5: State-of-the-art workshop on CAP infections.Pascal Van Bleyenbergh, Belgium
12:00 – 13:00 Pfizer Guest lecture
12:00 – 13:00 Lunch – Poster viewing – Exhibition
thursday17
PharmaCotheraPy: SeleCteD toPICS In InfeCtIonS
This is the preliminary programme on date of printing and is subject to change. For regular updates, please consult the website: www.escpweb.org
SCIentIfIC ProGramme of the Day
time afternoon Programme
13:00 – 14:00 oral Communications 1
14:00 – 16:00 Workshops 6 – 10 (The summaries of the workshops will be available on the symposium website by Mid March 2012.)
WS 6: Bacterial infections in pediatric oncology: theoretical and practi-cal issues. Tiene Bauters - Petra Schelstraete, BelgiumWS 7: Antimicrobial Stewardship - a Scottish perspective. Moira Kinnear, William MalcomAlison Coppen, United KingdomWS 8: Resistant Gram-negative infections: treatment decisions. Inge Gyssens, Belgium & The NetherlandWS 9: Supporting guidelines in infectious diseases: role of the pharmacist. Franky Buyle, Ina Van den Borre, Pieter-Jan Cortoos, Belgium & United KingdomWS 10: State-of-the-art workshop on infections related to travelling. Paul De Munter, Belgium
16:00 – 16:30 Coffee Break– Poster viewing – Exhibition
16:30 – 18:00 Plenary Session 2b:
16:30 – 17:00 l 2.4: Therapeutic drug monitoring of antimicrobial agents.Isabel Spriet, Pieter De Cock, Belgium
17:00 – 17:30 l 2.5: Invasive fungal infections: what should the clinical pharmacist know about it? Johan Maertens, Belgium
17:30 – 18:00 l 2.6: Opportunistic infections in immunosuppressed and cancer patients. Dirk Vogelaers, Belgium
19:30 Workshop Dinner at Faculty Club
24 27
Scientific ProgrammeFriday, 1 June 2012
Centrale Bibliotheek, Leuven
20 SCIentIfIC ProGramme of the Day
frid
ay
InfeCtIonS from a SoCIetal PerSPeCtIve
time morning Programme
08:00 – 09:30 Plenary Session 3a:
08:00 – 08:45 l 3.1: Vaccination: victim of its own success? Marc Van Ranst, Belgium
08:45 – 09:30 l 3.2: Effectiveness & cost-effectiveness of vaccination.Philippe Beutels, Belgium
09:30 – 10:00 Coffee Break– Poster viewing – Exhibition
10:00 – 12:00 Workshops 6 – 10 repeated (The summaries of the workshops will be available on the symposium website by Mid March 2012.)
WS 6: Bacterial infections in pediatric oncology: theoretical and practi-cal issues. Tiene Bauters, Petra Schelstraete, BelgiumWS 7: Antimicrobial Stewardship - a Scottish perspective. Moira Kinnear, William Malcom, Alison Coppen, United KingdomWS 8: Resistant Gram-negative infections: treatment decisions. Inge Gyssens, Belgium & The NetherlandsWS 9: Supporting guidelines in infectious diseases: role of the pharmacist. Franky Buyle, Ina Van den Borre, Pieter-Jan Cortoos, Belgium & United KingdomWS 10: State-of-the-art workshop on infections related to travelling. Paul De Munter, Belgium
12:00 – 13:00 vSm Guest lecture
12:00 – 13:00 Lunch – Poster viewing – Exhibition
afternoon Programme
13:00 – 14:00 oral Communications 2
14:00 – 15:30 Plenary Session 3a:
14:00 – 14:45 l 3.3: Antimicrobial pharmacist (UK): training & experience.Philip Howard, United Kingdom
14:45 – 15:30 l 3.4: Perspectives in antimicrobial agents.Paul Tulkens, Isabelle Huys, Belgium
15:30 – 16:00 Workshop Summary & Closing Ceremony
European Society of Clinical Pharmacy (ESCP)The European Society of Clinical Pharmacy (ESCP) was founded in October 1979 during the 8th European Symposium on Clinical Pharmacy in Lyon, France. The objective of the Society is to develop and promote the rational and appropriate use of drugs and medical devices for the benefit of individuals and of society. Each year the Society organises an Annual Symposium, usually held in October. At this Workshop, papers in the field of pharmacotherapy, pharmacokinetics, clinical practice and various other subjects related to the aims of ESCP are presented.
DisclaimerAll the information on the scientific and social programme, as outlined in this Provisional Programme, is subject to change in finalisation of the ESCP International Workshop Final Programme.
ImpressumGraphic design and layout: white suitcase, Geneva http://www.white-suitcase.ch
The following companies have provided generous sponsorship in support of the ESCP International Workshop on ‘Patients, Infections and the Clinical Pharmacist’:
ESCP 2012 Workshop partnerPfizer
Sponsors & exhibitorsJanssen-Cilag nvRocheVSM BelgiumFWO-Vlaanderen
This list reflects to the companies/organisations that confirmed before 12 January 2012.
Important Dates & DeadlinesAbstract submission deadline: 5 March 2012;Early bird registration deadline: 5 March 2012;Early bird registration deadline for accepted
abstract submitters: 20 April 2012;Pre-registration deadline: 23 May 2012;
After this date, registrations on-site only;Hotel reservation deadline:16 April 2012;The number of participants will be
limited to 200.
